The angiogenic capacity from ligamentum flavum subsequent to inflammation: A critical component of the pathomechanism of hypertrophy

Spine

Volumn 37, Issue 3, 2012, Pages

  Moon, Hong Joo ^a   Park, Youn Kwan ^a   Ryu, Youngjoon ^a   Kim, Jong Hyun ^a   Kwon, Taek Hyun ^a   Chung, Hung Seob ^a   Kim, Joo Han ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

angiogenesis; human monocytic THP 1 cell line; hypertrophy; inflammation; ligamentum flavum

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PHORBOL 13 ACETATE 12 MYRISTATE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL INTERACTION; CELL VIABILITY; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIGAMENT DISEASE; LIGAMENTUM FLAVUM; LIGAMENTUM FLAVUM HYPERTROPHY; MACROPHAGE ACTIVATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SECRETION;

CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; FIBROSIS; HUMANS; HYPERTROPHY; INFLAMMATION; LIGAMENTUM FLAVUM; MACROPHAGES; MONOCYTES; NEOVASCULARIZATION, PHYSIOLOGIC; SPINAL STENOSIS;

EID: 84856692467     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3182269b19     Document Type: Article

References (46)

1. Spivak JM. Degenerative lumbar spinal stenosis. J Bone Joint Surg Am 1998; 80: 1053-66. (Pubitemid 28355677)
2. Beamer YB, Garner JT, Shelden CH. Hypertrophied ligamentum flavum. Clinical and surgical significance. Arch Surg 1973; 106: 289-92.
3. Park JB, Chang H, Lee JK. Quantitative analysis of transforming growth factor-beta 1 in ligamentum flavum of lumbar spinal stenosis and disc herniation. Spine (Phila Pa 1976) 2001; 26: E492-5.
4. Sairyo K, Biyani A, Goel VK, et al. Lumbar ligamentum flavum hypertrophy is due to accumulation of inflammation-related scar tissue. Spine (Phila Pa 1976) 2007; 32: E340-7. (Pubitemid 46743031)
5. Towne EB, Reichert FL. Compression of the lumbosacral roots of the spinal cord by thickened ligamenta flava. Ann Surg 1931; 94: 327-36.
6. Epstein NE. Lumbar spinal stenosis. In: Winn HR, ed. Neurological Surgery. 5th ed. Philadelphia, PA: Saunders; 2004: 4521-39.
7. Nakatani T, Marui T, Hitora T, et al. Mechanical stretching force promotes collagen synthesis by cultured cells from human ligamentum flavum via transforming growth factor-beta1. J Orthop Res 2002; 20: 1380-6. (Pubitemid 35364000)
8. Sairyo K, Biyani A, Goel V, et al. Pathomechanism of ligamentum flavum hypertrophy: a multidisciplinary investigation based on clinical, biomechanical, histologic, and biologic assessments. Spine (Phila Pa 1976) 2005; 30: 2649-56. (Pubitemid 41780375)
9. Park JB, Kong CG, Suhl KH, et al. The increased expression of matrix metalloproteinases associated with elastin degradation and fibrosis of the ligamentum flavum in patients with lumbar spinal stenosis. Clin Orthop Surg 2009; 1: 81-9.
10. Park JB, Lee JK, Park SJ, et al. Hypertrophy of ligamentum flavum in lumbar spinal stenosis associated with increased proteinase inhibitor concentration. J Bone Joint Surg Am 2005; 87: 2750-7.
11. Kosaka H, Sairyo K, Biyani A, et al. Pathomechanism of loss of elasticity and hypertrophy of lumbar ligamentum flavum in elderly patients with lumbar spinal canal stenosis. Spine (Phila Pa 1976) 2007; 32: 2805-11. (Pubitemid 351339349)
12. Okuda T, Baba I, Fujimoto Y, et al. The pathology of ligamentum flavum in degenerative lumbar disease. Spine (Phila Pa 1976) 2004; 29: 1689-97. (Pubitemid 39014850)
13. Schräder PK, Grob D, Rahn BA, et al. Histology of the ligamentum flavum in patients with degenerative lumbar spinal stenosis. Eur Spine J 1999; 8: 323-8. (Pubitemid 29390136)
14. Yoshida M, Shima K, Taniguchi Y, et al. Hypertrophied ligamentum flavum in lumbar spinal canal stenosis. Pathogenesis and morphologic and immunohistochemical observation. Spine (Phila Pa 1976) 1992; 17: 1353-60.
15. Frangogiannis NG. Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflamm Res 2004; 53: 585-95. (Pubitemid 40385316)
16. Wilgus TA, Vodovotz Y, Vittadini E, et al. Reduction of scar formation in full-thickness wounds with topical celecoxib treatment. Wound Repair Regen 2003; 11: 25-34. (Pubitemid 36268606)
17. Furuichi K, Kaneko S, Wada T. Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney disease. Clin Exp Nephrol 2009; 13: 9-14.
18. Strieter RM, Mehrad B. New mechanisms of pulmonary fibrosis. Chest 2009; 136: 1364-70.
19. Colwell AS, Beanes SR, Soo C, et al. Increased angiogenesis and expression of vascular endothelial growth factor during scarless repair. Plast Reconstr Surg 2005; 115: 204-12. (Pubitemid 40187816)
20. Kumar I, Staton CA, Cross SS, et al. Angiogenesis, vascular endothelial growth factor and its receptors in human surgical wounds. Br J Surg 2009; 96: 1484-91.
21. Hughes CC. Endothelial-stromal interactions in angiogenesis. Curr Opin Hematol 2008; 15: 204-9. (Pubitemid 351507572)
22. Li J, Zhang YP, Kirsner RS. Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microsc Res Tech 2003; 60: 107-14. (Pubitemid 36055239)
23. Bucala R, Spiegel LA, Chesney J, et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994; 1: 71-81.
24. Direkze NC, Forbes SJ, Brittan M, et al. Multiple organ engraftment by bone-marrow-derived myofibroblasts and fibroblasts in bonemarrow-transplanted mice. Stem Cells 2003; 21: 514-20. (Pubitemid 37444107)
25. Ebihara Y, Masuya M, Larue AC, et al. Hematopoietic origins of fibroblasts: II. In vitro studies of fibroblasts, CFU-F, and fibrocytes. Exp Hematol 2006; 34: 219-29. (Pubitemid 43184327)
26. Enzerink A, Rantanen V, Vaheri A. Fibroblast nemosis induces angiogenic responses of endothelial cells. Exp Cell Res 2010; 316: 826-35.
27. Bauer SM, Bauer RJ, Liu ZJ, et al. Vascular endothelial growth factor-C promotes vasculogenesis, angiogenesis, and collagen constriction in three-dimensional collagen gels. J Vasc Surg 2005; 41: 699-707. (Pubitemid 40637671)
28. Bao P, Kodra A, Tomic-Canic M, et al. The role of vascular endothelial growth factor in wound healing. J Surg Res 2009; 153: 347-58.
29. Miller-Kasprzak E, Jagodziński PP. Endothelial progenitor cells as a new agent contributing to vascular repair. Arch Immunol Ther Exp (Warsz) 2007; 55: 247-59. (Pubitemid 47262710)
30. Fan Y, Ye J, Shen F, et al. Interleukin-6 stimulates circulating bloodderived endothelial progenitor cell angiogenesis in vitro. J Cereb Blood Flow Metab 2008; 28: 90-8.
31. Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258: 1798-801. (Pubitemid 23087348)
32. Li A, Varney ML, Valasek J, et al. Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis 2005; 8: 63-71. (Pubitemid 41223840)
33. Tsuchiya S, Kobayashi Y, Goto Y, et al. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 1982; 42: 1530-6. (Pubitemid 12148801)
34. Satsu H, Ishimoto Y, Nakano T, et al. Induction by activated macrophage-like THP-1 cells of apoptotic and necrotic cell death in intestinal epithelial Caco-2 monolayers via tumor necrosis factoralpha. Exp Cell Res 2006; 312: 3909-19. (Pubitemid 44633890)
35. Takashiba S, Van Dyke TE, Amar S, et al. Differentiation of monocytes to macrophages primes cells for lipopolysaccharide stimulation via accumulation of cytoplasmic nuclear factor kappaB. Infect Immun 1999; 67: 5573-8. (Pubitemid 29508072)
36. Fukuyama S, Nakamura T, Ikeda T, et al. The effect of mechanical stress on hypertrophy of the lumbar ligamentum flavum. J Spinal Disord 1995; 8: 126-30.
37. Nakamura T, Hashimoto N, Maeda Y, et al. Degeneration and ossification of the yellow ligament in unstable spine. J Spinal Disord 1990; 3: 288-92.
38. Gruber HE, Hoelscher GL, Leslie K, et al. Three-dimensional culture of human disc cells within agarose or a collagen sponge: assessment of proteoglycan production. Biomaterials 2006; 27: 371-6. (Pubitemid 41457240)
39. Horner HA, Roberts S, Bielby RC, et al. Cells from different regions of the intervertebral disc: effect of culture system on matrix expression and cell phenotype. Spine (Phila Pa 1976) 2002; 27: 1018-28. (Pubitemid 34527146)
40. Kim JH, Studer RK, Sowa GA, et al. Activated macrophage-like THP-1 cells modulate anulus fibrosus cell production of inflammatory mediators in response to cytokines. Spine (Phila Pa 1976) 2008; 33: 2253-9.
41. Oquendo J, Dubanchet S, Capel F, et al. Suppressive effect of hepatitis B virus on the induction of interleukin-1 beta and interleukin-6 gene expression in the THP-1 human monocytic cell line. Eur Cytokine Netw 1996; 7: 793-800. (Pubitemid 27056459)
42. Ito H. Anti-interleukin-6 therapy for Crohn's disease. Curr Pharm Des 2003; 9: 295-305. (Pubitemid 36131724)
43. Romano M, Sironi M, Toniatti C, et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997; 6: 315-25. (Pubitemid 27148598)
44. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214: 199-210. (Pubitemid 351160157)
45. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998; 16: 137-61.
46. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. J Cell Sci 2003; 116: 217-24. (Pubitemid 36163863)